Clinical Trial Update: The Efficacy and Safety of Deucravacitinib in Takayasu's Arteritis [Phase 4]

View source ↗

Summary

Phase 4 trial investigating the efficacy and safety of Deucravacitinib for Takayasu arteritis; recruitment has not yet begun.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Takayasu Arteritis

Drugs mentioned

• Sotyktu (Deucravacitinib)

Snippet

Sponsor: Chinese SLE Treatment And Research Group | Conditions: Takayasu Arteritis (TAK) | Phase 4 | Status: NOT_YET_RECRUITING